Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Biopharmaceuticals Inc Accentia currently holds 80,962,482 shares of BIOVEST INTERNATIONAL INC (BVTI.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biopharmaceuticals Inc Accentia has been a net buyer of BVTI.OB stock. They have purchased $153.5K and sold $0 worth of shares.
Biopharmaceuticals Inc Accentia's most recent insider trade was on Feb 22, 2013, when they sold 4,794,373 shares at $0.12 per share.
Biopharmaceuticals Inc Accentia serves as Executive at BIOVEST INTERNATIONAL INC (BVTI.OB). They have executed 24 insider transactions totaling $153.5K over their tenure at the company.
Biopharmaceuticals Inc Accentia holds the position of Executive at BIOVEST INTERNATIONAL INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Biopharmaceuticals Inc Accentia has shown a buying trading pattern, with $153.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Biopharmaceuticals Inc Accentia was on Feb 7, 2005, when they sold $8.0M worth of BVTI shares. This transaction involved 16,043,722 shares at $0.50 per share.
Biopharmaceuticals Inc Accentia currently owns 80,962,482 shares of BIOVEST INTERNATIONAL INC (BVTI.OB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Biopharmaceuticals Inc Accentia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Biopharmaceuticals Inc Accentia has 24 Form 4 filings on record as an insider at BIOVEST INTERNATIONAL INC.
Set alerts for Biopharmaceuticals Inc Accentia and 40,000+ other insiders.